EVANSVILLE, Ind. (WFIE) - The arrival of a coronavirus vaccine is providing some hope that we will soon be able to put the pandemic behind us.
Should the COVID-19 vaccines get approved for emergency use, Deaconess says their staff has been educated about it and they are ready to have this first line of defense in the pandemic.
One of the main concerns addressed by skeptics in regard to the vaccine is that it could alter someone’s DNA. One doctor at Deaconess tells 14 News this is simply not true.
He says this COVID-19 vaccine is a new type of technology and it inserts RNA into the patient’s system, and this will essentially help create antibodies to fight off the virus.
Doctors understand people could be concerned, but they don’t want this to scare anyone from getting the vaccine, which could cause a much worse situation.
“I think there’s a lot of myths and a lot of concerns out there, but I have the utmost confidence in our FDA that they are going to go through the process to make sure this is a safe vaccine for our patients,” said Dr. Brad Scheu with the Deaconess Health System. “It’s something we will continue to monitor very closely. I don’t have any concerns about safety.”
It’s also important to note the vaccine does not give someone COVID-19. When the vaccine is available, it will come in two doses for the general public.
Deaconess officials say they don’t know how many doses they will receive in Henderson. They say those will come from Kentucky.
As for Indiana, health system leaders say the state tells them they will receive 1,950 doses of the Pfizer vaccine early next week.
Deaconess leaders anticipate giving the first doses as early as Wednesday, December 16. These vaccines will be administered daily, alternating between two sites - Deaconess Midtown Hospital in Evansville and Deaconess Gateway Hospital in Warrick County.
During the following week, officials say they will open up another location to vaccinate healthcare workers from five surrounding counties.
They say the state is overseeing the notification and scheduling process for those workers.
Officials say they expect to receive a larger allocation during the second week, which could be Pfizer, Moderna, or both.
Officials also say they are hiring volunteers and staff to help distribute the vaccine. They will use state guidance to get the vaccine into the arms of the public.